[go: up one dir, main page]

Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery

Expert Opin Ther Targets. 2007 May;11(5):695-705. doi: 10.1517/14728222.11.5.695.

Abstract

Nicotinamide adenine dinucleotide (NAD(+)) has crucial roles in many cellular processes, both as a coenzyme for redox reactions and as a substrate to donate ADP-ribose units. Enzymes involved in NAD(+) metabolism are attractive targets for drug discovery against a variety of human diseases, including cancer, multiple sclerosis, neurodegeneration and Huntington's disease. A small-molecule inhibitor of nicotinamide phosphoribosyltransferase, an enzyme in the salvage pathway of NAD(+) biosynthesis, is presently in clinical trials against cancer. An analog of a kynurenine pathway intermediate is efficacious against multiple sclerosis in an animal model. Indoleamine 2,3-dioxygenase plays an important role in immune evasion by cancer cells and other disease processes. Inhibitors against kynurenine 3-hydroxylase can reduce the production of neurotoxic metabolites while increasing the production of neuroprotective compounds. This review summarizes the existing knowledge on NAD(+) metabolic enzymes, with emphasis on their relevance for drug discovery.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Acrylamides / pharmacology
  • Acrylamides / therapeutic use
  • Adenosine Diphosphate Ribose / metabolism
  • Aging / metabolism
  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / metabolism
  • Clinical Trials, Phase II as Topic
  • Cyclic ADP-Ribose / physiology
  • DNA Damage
  • Drug Design*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Kynurenine / metabolism
  • Mice
  • NAD / metabolism*
  • NAD / physiology
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / metabolism
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use
  • Piperidines / pharmacology
  • Piperidines / therapeutic use
  • Poly Adenosine Diphosphate Ribose / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Sirtuins / antagonists & inhibitors
  • Sirtuins / metabolism
  • Tryptophan / metabolism

Substances

  • Acrylamides
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide
  • Neuroprotective Agents
  • Piperidines
  • NAD
  • Cyclic ADP-Ribose
  • Adenosine Diphosphate Ribose
  • Poly Adenosine Diphosphate Ribose
  • Kynurenine
  • Tryptophan
  • Sirtuins